VeriMomlavandula angustifolia extract은 임신 중 안전한가요?
No EU Annex II/III listing or harmonised reproductive H‑code was found for Lavandula angustifolia extract (CAS 90063-37-9). Regulatory and authoritative reviews (ECHA substance entry; EMA/HMPC overview) report no major reproductive safety concerns for lavender preparations, and peer‑reviewed studies located concern skin biology or topical effects rather than developmental/reproductive toxicity. Sources: ECHA substance information; EMA HMPC overview; PubMed search found no reproductive/developmental animal data for the extract. (ECHA; EMA; PubMed).
Pregnancy-safe products containing lavandula angustifolia extract
Related ingredients
Frequently asked questions
- lavandula angustifolia extract은 임신 중 안전한가요?
- No EU Annex II/III listing or harmonised reproductive H‑code was found for Lavandula angustifolia extract (CAS 90063-37-9). Regulatory and authoritative reviews (ECHA substance entry; EMA/HMPC overview) report no major reproductive safety concerns for lavender preparations, and peer‑reviewed studies located concern skin biology or topical effects rather than developmental/reproductive toxicity. Sources: ECHA substance information; EMA HMPC overview; PubMed search found no reproductive/developmental animal data for the extract. (ECHA; EMA; PubMed).
- lavandula angustifolia extract은 모유 수유 중 안전한가요?
- No evidence in regulatory dossiers, SCCS/CIR opinions, or peer‑reviewed literature that Lavandula angustifolia extract causes reproductive or lactation-specific toxicity or transfers in amounts of concern via topical application. Major safety databases (ECHA, EWG Skin Deep) list allergy/irritancy as the primary concerns rather than lactation or developmental toxicity.
- lavandula angustifolia extract은 아기 피부에 안전한가요?
- Hazard/mechanism evidence for reproductive or developmental toxicity is absent, so h/m remain 0. Exposure (e) is increased by +1 for infants because infant skin has higher permeability and the ingredient is topically applied; although the extract itself is not reported as highly systemically bioavailable, neonatal skin immaturity makes measurable absorption more likely than in adults. Primary concerns remain topical irritation/allergy rather than developmental toxicity.
- VeriMom은 lavandula angustifolia extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 lavandula angustifolia extract을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 lavandula angustifolia extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.